Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID -- Ignore unavailable to you. Want to Upgrade?

To: I. Luttichuys who wrote (1344)	10/29/1997 11:35:00 AM
From: DZOO	Respond to of 1762

To All:IDEC Pharmaceuticals Corp. (IDPH) 37 7/8 +2 1/4: SBC Warburg Dillon Read ups rating on drug developer to a "buy" from an "outperform" recommendation.....

To: I. Luttichuys who wrote (1344)	11/1/1997 9:21:00 AM
From: Gary105	Read Replies (1) \| Respond to of 1762

O.T., Hello Bennett, do you have any thoughts on TEVIY? Its an Israeli owned company that does most of its business in the U.S. - a lot of generics and a treatment for MS. Its retreated quite a bit despite strong growth projections - obviously a disconnect between projected earnings and price and I'm trying to determine which parameter is out of line. Any thoughts? Gary